Download the Full Event Guide
With participation from over 70 senior ESG professionals representing leading organizations including BioMarin Pharmaceutical, Takeda, AbbVie, the U.S. Environmental Protection Agency, Dexcom, Genentech, and more, this summit delivers a rare opportunity to benchmark against your peers and co-create solutions to shared challenges in a focused, high-impact setting.
With a niche, senior-level audience and an intimate format designed for deep interaction, this meeting fosters genuine collaboration -amplifying the chances of connecting with peers grappling with the same issues and surfacing replicable, actionable solutions.
Whether you're building a reporting roadmap, aligning sustainability goals with business outcomes, or embedding ESG into your supply chain and R&D processes, ESG in Life Sciences West is your platform to shape what ESG success looks like in 2025 and beyond.
Here’s a sneak peak of what will be covered:
- Navigating the New Executive Order on Regulations to Future-Proof Compliance
- Tackling Scope 3 & Supplier Engagement to Increase Value Chain Sustainability Impact
- Streamlining CSRD Disclosures: Traversing European Reporting Requirement with Confidence
- Optimizing ESG Practices Across the Business: Fostering Internal Buy-In, Choosing the Right Projects, & Prioritizing Long-Term Sustainability
Download the agenda to see what sessions are included under these themes.
Having trouble downloading?
Let us know here and we’ll email it to you instead
Companies Attending Include:
